bucladesine and Blood Clot

bucladesine has been researched along with Blood Clot in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Archipoff, G; Bartha, K; Beretz, A; Brisson, C; Cazenave, JP; de la Salle, C; Froget-Léon, C; Klein-Soyer, C1
Fukui, H; Kitagami, K; Matsumoto, M; Nakano, H; Nakayama, M; Okamoto, Y; Tsujii, T1

Other Studies

2 other study(ies) available for bucladesine and Blood Clot

ArticleYear
Role of cyclic AMP in promoting the thromboresistance of human endothelial cells by enhancing thrombomodulin and decreasing tissue factor activities.
    British journal of pharmacology, 1993, Volume: 109, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Alprostadil; Base Sequence; Bucladesine; Cells, Cultured; Colforsin; Cyclic AMP; Dibutyryl Cyclic GMP; Endothelium, Vascular; Humans; Immunoenzyme Techniques; Kinetics; Microscopy, Immunoelectron; Molecular Sequence Data; Polymerase Chain Reaction; Receptors, Cell Surface; Receptors, Thrombin; RNA; RNA-Directed DNA Polymerase; Saphenous Vein; Thrombin; Thromboplastin; Thrombosis

1993
[Effect of dibutyryl cyclic AMP in the treatment of hepatocellular carcinoma--intraarterial infusion therapy combined with anticancer agent for hepatocellular carcinoma with portal vein thrombosis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bucladesine; Carcinoma, Hepatocellular; Doxorubicin; Female; Humans; Infusion Pumps; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Portal Vein; Thrombosis

1992